A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care
Our purpose was to explore antidepressant drug (AD) prescribing patterns in Italian primary care.
Overall, 276 Italian general practitioners (GPs) participated in this prospective study, recruiting patients >18 years who started AD therapy during the enrolment period (January 2007 to June 2008). During visits at baseline and 3, 6, and 12 months, data about patients’ characteristics and AD treatments were collected by the GPs. Discontinuation rate among new users of AD classes [i.e., selective serotonin reuptake inhibitors (SSRI); tricyclics (TCAs); other ADs) were compared. Logistic regression analyses were performed to identify predictors of AD discontinuation.
SSRIs were the most frequently prescribed ADs (N = 1,037; 75.3 %), especially paroxetine and escitalopram. SSRIs were more likely to be prescribed because of depressive disorders (80 %), and by GPs (51.1 %) rather than psychiatrists (31.8 %). Overall, 27.5 % (N = 378) of AD users discontinued therapy during the first year, mostly in the first 3 months (N = 242; 17.6 %), whereas 185 (13.4 %) were lost to follow-up. SSRI users showed the highest discontinuation rate (29 %). In patients with depressive disorders, younger age, psychiatrist-based diagnosis, and treatment started by GPs were independent predictors of SSRI discontinuation.
In Italy, ADs—especially SSRIs—are widely prescribed by GPs because of depressive/anxiety disorders. Active monitoring of AD users in general practice might reduce the AD discontinuation rate.
KeywordsGeneral practice Antidepressives Pharmacoepidemiology Italy
This study was funded by the Italian Drug Agency through a national grant dedicated to pharmacovigilance projects.
Conflict of interest
- 1.Haden ACB (2001) The world health report 2001.Mental health: new understanding, new hope. World Health Organization, Geneva, 30.2001Google Scholar
- 5.Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R et al Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial. Trials 11:99Google Scholar
- 11.Svab V, Subelj M, Vidmar G Prescribing changes in anxiolytics and antidepressants in Slovenia. Psychiatr Danub 23:178–182Google Scholar
- 12.Demyttenaere K, Bonnewyn A, Bruffaerts R, De Girolamo G, Gasquet I, Kovess V et al (2008) Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disord 110:84–93PubMedCrossRefGoogle Scholar
- 21.Guaiana G, Andretta M, Griez E, Biancosino B, Grassi L Sales of antidepressants, suicides and hospital admissions for depression in Veneto Region, Italy, from 2000 to 2005: an ecological study. Ann Gen Psychiatry 10:24Google Scholar
- 24.Evaluation of prescribing pattern and safety profile of antidepressant and antipsychotic medications in Italian general practiceGoogle Scholar
- 25.Spina E, Trifiro G, Caraci F Clinically significant drug interactions with newer antidepressants. CNS drugs 26:39–67Google Scholar
- 27.Agenzia Italiana del Farmaco A (2010) Rapporto gennaio-settembre 2010Google Scholar
- 29.Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G et al (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (Oxford, England) 22:343–396CrossRefGoogle Scholar
- 32.Andersson Sundell K, Waern M, Petzold M, Gissler M (2011) Socio-economic determinants of early discontinuation of anti-depressant treatment in young adults. Eur J Public HealthGoogle Scholar